nodes	percent_of_prediction	percent_of_DWPC	metapath
Degarelix—GNRHR—Peptide GPCRs—EDNRA—migraine	0.0101	0.0437	CbGpPWpGaD
Degarelix—GNRHR—GPCRs, Other—EDNRA—migraine	0.00852	0.037	CbGpPWpGaD
Degarelix—GNRHR—G alpha (q) signalling events—HTR2B—migraine	0.00813	0.0353	CbGpPWpGaD
Degarelix—GNRHR—GPCRs, Other—HTR7—migraine	0.00768	0.0333	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.00727	0.0316	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CALCRL—migraine	0.00607	0.0264	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—RAMP1—migraine	0.00607	0.0264	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.00579	0.0251	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.00538	0.0234	CbGpPWpGaD
Degarelix—GNRHR—GPCRs, Other—HTR2A—migraine	0.00538	0.0233	CbGpPWpGaD
Degarelix—GNRHR—G alpha (q) signalling events—TAC1—migraine	0.00502	0.0218	CbGpPWpGaD
Degarelix—GNRHR—G alpha (q) signalling events—NPS—migraine	0.00502	0.0218	CbGpPWpGaD
Degarelix—GNRHR—G alpha (q) signalling events—HTR2C—migraine	0.00493	0.0214	CbGpPWpGaD
Degarelix—GNRHR—G alpha (q) signalling events—EDNRA—migraine	0.00479	0.0208	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.00449	0.0195	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.00449	0.0195	CbGpPWpGaD
Degarelix—GNRHR—brainstem—migraine	0.00444	0.288	CbGeAlD
Degarelix—GNRHR—GPCR ligand binding—HTR1D—migraine	0.00441	0.0191	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.00441	0.0191	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.00429	0.0186	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—HTR2B—migraine	0.0041	0.0178	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.00351	0.0152	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—RAMP1—migraine	0.00343	0.0149	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—CALCRL—migraine	0.00343	0.0149	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.00338	0.0147	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.00333	0.0144	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.00333	0.0144	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.00326	0.0142	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.00317	0.0138	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CALCRL—migraine	0.00311	0.0135	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—RAMP1—migraine	0.00311	0.0135	CbGpPWpGaD
Degarelix—GNRHR—G alpha (q) signalling events—HTR2A—migraine	0.00302	0.0131	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.00286	0.0124	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.0027	0.0117	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—HTR1B—migraine	0.00267	0.0116	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—HTR1A—migraine	0.00257	0.0112	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—TAC1—migraine	0.00253	0.011	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—NPS—migraine	0.00253	0.011	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—HTR1D—migraine	0.00249	0.0108	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—HTR2C—migraine	0.00248	0.0108	CbGpPWpGaD
Degarelix—GNRHR—head—migraine	0.00245	0.159	CbGeAlD
Degarelix—GNRHR—GPCR ligand binding—EDNRA—migraine	0.00242	0.0105	CbGpPWpGaD
Degarelix—GNRHR—nervous system—migraine	0.00233	0.151	CbGeAlD
Degarelix—GNRHR—GPCR ligand binding—CALCA—migraine	0.00233	0.0101	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—HTR2B—migraine	0.00232	0.0101	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—HTR1D—migraine	0.00226	0.00983	CbGpPWpGaD
Degarelix—GNRHR—central nervous system—migraine	0.00224	0.145	CbGeAlD
Degarelix—GNRHR—cerebellum—migraine	0.00219	0.142	CbGeAlD
Degarelix—GNRHR—GPCR ligand binding—HTR7—migraine	0.00218	0.00945	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—HTR2B—migraine	0.0021	0.00913	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.002	0.00869	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—RAMP1—migraine	0.00184	0.00799	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CALCRL—migraine	0.00184	0.00799	CbGpPWpGaD
Degarelix—GNRHR—brain—migraine	0.00178	0.115	CbGeAlD
Degarelix—Acute coronary syndrome—Gabapentin—migraine	0.00168	0.00223	CcSEcCtD
Degarelix—Renal failure—Gabapentin—migraine	0.00168	0.00222	CcSEcCtD
Degarelix—Angiopathy—Valproic Acid—migraine	0.00168	0.00222	CcSEcCtD
Degarelix—Insomnia—Verapamil—migraine	0.00167	0.00222	CcSEcCtD
Degarelix—Myocardial infarction—Gabapentin—migraine	0.00167	0.00222	CcSEcCtD
Degarelix—Immune system disorder—Valproic Acid—migraine	0.00167	0.00221	CcSEcCtD
Degarelix—Mediastinal disorder—Valproic Acid—migraine	0.00166	0.00221	CcSEcCtD
Degarelix—Urinary tract infection—Gabapentin—migraine	0.00166	0.0022	CcSEcCtD
Degarelix—Chills—Valproic Acid—migraine	0.00166	0.0022	CcSEcCtD
Degarelix—Arrhythmia—Valproic Acid—migraine	0.00165	0.00219	CcSEcCtD
Degarelix—Dyspnoea—Verapamil—migraine	0.00165	0.00219	CcSEcCtD
Degarelix—Gastrointestinal pain—Propranolol—migraine	0.00164	0.00218	CcSEcCtD
Degarelix—Muscular weakness—Topiramate—migraine	0.00164	0.00218	CcSEcCtD
Degarelix—Dizziness—Amitriptyline—migraine	0.00163	0.00217	CcSEcCtD
Degarelix—Alopecia—Valproic Acid—migraine	0.00163	0.00216	CcSEcCtD
Degarelix—Oedema peripheral—Timolol—migraine	0.00162	0.00215	CcSEcCtD
Degarelix—Mental disorder—Valproic Acid—migraine	0.00162	0.00214	CcSEcCtD
Degarelix—Hepatobiliary disease—Gabapentin—migraine	0.00161	0.00214	CcSEcCtD
Degarelix—Malnutrition—Valproic Acid—migraine	0.00161	0.00213	CcSEcCtD
Degarelix—Urticaria—Propranolol—migraine	0.0016	0.00212	CcSEcCtD
Degarelix—Fatigue—Verapamil—migraine	0.0016	0.00211	CcSEcCtD
Degarelix—Abdominal pain—Propranolol—migraine	0.00159	0.00211	CcSEcCtD
Degarelix—Body temperature increased—Propranolol—migraine	0.00159	0.00211	CcSEcCtD
Degarelix—Constipation—Verapamil—migraine	0.00158	0.0021	CcSEcCtD
Degarelix—Pain—Verapamil—migraine	0.00158	0.0021	CcSEcCtD
Degarelix—Vomiting—Amitriptyline—migraine	0.00157	0.00208	CcSEcCtD
Degarelix—Rash—Amitriptyline—migraine	0.00156	0.00206	CcSEcCtD
Degarelix—Dermatitis—Amitriptyline—migraine	0.00156	0.00206	CcSEcCtD
Degarelix—Back pain—Valproic Acid—migraine	0.00155	0.00206	CcSEcCtD
Degarelix—Headache—Amitriptyline—migraine	0.00155	0.00205	CcSEcCtD
Degarelix—Muscle spasms—Valproic Acid—migraine	0.00155	0.00205	CcSEcCtD
Degarelix—Abdominal discomfort—Topiramate—migraine	0.00154	0.00204	CcSEcCtD
Degarelix—Eye disorder—Timolol—migraine	0.00154	0.00204	CcSEcCtD
Degarelix—Cardiac disorder—Timolol—migraine	0.00153	0.00202	CcSEcCtD
Degarelix—Feeling abnormal—Verapamil—migraine	0.00152	0.00202	CcSEcCtD
Degarelix—GNRHR—GPCR ligand binding—HTR2A—migraine	0.00152	0.00662	CbGpPWpGaD
Degarelix—Hypoaesthesia—Gabapentin—migraine	0.00152	0.00202	CcSEcCtD
Degarelix—Vision blurred—Valproic Acid—migraine	0.00151	0.00201	CcSEcCtD
Degarelix—Urinary tract disorder—Gabapentin—migraine	0.00151	0.002	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—HTR1B—migraine	0.00151	0.00656	CbGpPWpGaD
Degarelix—Oedema peripheral—Gabapentin—migraine	0.00151	0.002	CcSEcCtD
Degarelix—Dysuria—Topiramate—migraine	0.0015	0.00199	CcSEcCtD
Degarelix—Urethral disorder—Gabapentin—migraine	0.0015	0.00199	CcSEcCtD
Degarelix—Ill-defined disorder—Valproic Acid—migraine	0.00149	0.00198	CcSEcCtD
Degarelix—Angiopathy—Timolol—migraine	0.00149	0.00198	CcSEcCtD
Degarelix—Pollakiuria—Topiramate—migraine	0.00149	0.00197	CcSEcCtD
Degarelix—Anaemia—Valproic Acid—migraine	0.00149	0.00197	CcSEcCtD
Degarelix—Immune system disorder—Timolol—migraine	0.00148	0.00197	CcSEcCtD
Degarelix—Hypersensitivity—Propranolol—migraine	0.00148	0.00196	CcSEcCtD
Degarelix—Erectile dysfunction—Topiramate—migraine	0.00148	0.00196	CcSEcCtD
Degarelix—Mediastinal disorder—Timolol—migraine	0.00148	0.00196	CcSEcCtD
Degarelix—Urticaria—Verapamil—migraine	0.00147	0.00195	CcSEcCtD
Degarelix—Arrhythmia—Timolol—migraine	0.00147	0.00195	CcSEcCtD
Degarelix—Nausea—Amitriptyline—migraine	0.00147	0.00195	CcSEcCtD
Degarelix—Weight increased—Topiramate—migraine	0.00146	0.00194	CcSEcCtD
Degarelix—Weight decreased—Topiramate—migraine	0.00146	0.00193	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—HTR1A—migraine	0.00145	0.00631	CbGpPWpGaD
Degarelix—Alopecia—Timolol—migraine	0.00145	0.00193	CcSEcCtD
Degarelix—Hyperglycaemia—Topiramate—migraine	0.00145	0.00192	CcSEcCtD
Degarelix—Malaise—Valproic Acid—migraine	0.00145	0.00192	CcSEcCtD
Degarelix—Asthenia—Propranolol—migraine	0.00144	0.00191	CcSEcCtD
Degarelix—Mental disorder—Timolol—migraine	0.00144	0.00191	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—NPS—migraine	0.00143	0.00621	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—TAC1—migraine	0.00143	0.00621	CbGpPWpGaD
Degarelix—Erythema—Timolol—migraine	0.00143	0.0019	CcSEcCtD
Degarelix—Malnutrition—Timolol—migraine	0.00143	0.0019	CcSEcCtD
Degarelix—Eye disorder—Gabapentin—migraine	0.00143	0.0019	CcSEcCtD
Degarelix—Depression—Topiramate—migraine	0.00143	0.0019	CcSEcCtD
Degarelix—Cardiac disorder—Gabapentin—migraine	0.00142	0.00188	CcSEcCtD
Degarelix—Palpitations—Valproic Acid—migraine	0.00142	0.00188	CcSEcCtD
Degarelix—Renal failure—Topiramate—migraine	0.00141	0.00187	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—HTR2C—migraine	0.0014	0.00609	CbGpPWpGaD
Degarelix—Urinary tract infection—Topiramate—migraine	0.00139	0.00185	CcSEcCtD
Degarelix—Hypertension—Valproic Acid—migraine	0.00139	0.00184	CcSEcCtD
Degarelix—Immune system disorder—Gabapentin—migraine	0.00138	0.00183	CcSEcCtD
Degarelix—Mediastinal disorder—Gabapentin—migraine	0.00138	0.00183	CcSEcCtD
Degarelix—Diarrhoea—Propranolol—migraine	0.00138	0.00182	CcSEcCtD
Degarelix—Chills—Gabapentin—migraine	0.00137	0.00182	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—HTR1B—migraine	0.00137	0.00595	CbGpPWpGaD
Degarelix—Arthralgia—Valproic Acid—migraine	0.00137	0.00181	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—EDNRA—migraine	0.00137	0.00593	CbGpPWpGaD
Degarelix—Hypersensitivity—Verapamil—migraine	0.00136	0.00181	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.00136	0.0018	CcSEcCtD
Degarelix—Alopecia—Gabapentin—migraine	0.00135	0.00179	CcSEcCtD
Degarelix—Discomfort—Valproic Acid—migraine	0.00135	0.00179	CcSEcCtD
Degarelix—Vision blurred—Timolol—migraine	0.00135	0.00179	CcSEcCtD
Degarelix—Mental disorder—Gabapentin—migraine	0.00134	0.00178	CcSEcCtD
Degarelix—Dry mouth—Valproic Acid—migraine	0.00134	0.00177	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—HTR1D—migraine	0.00134	0.0058	CbGpPWpGaD
Degarelix—Malnutrition—Gabapentin—migraine	0.00133	0.00177	CcSEcCtD
Degarelix—Erythema—Gabapentin—migraine	0.00133	0.00177	CcSEcCtD
Degarelix—Dizziness—Propranolol—migraine	0.00133	0.00176	CcSEcCtD
Degarelix—Asthenia—Verapamil—migraine	0.00133	0.00176	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—HTR1A—migraine	0.00132	0.00573	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—CALCA—migraine	0.00131	0.00571	CbGpPWpGaD
Degarelix—Anaphylactic shock—Valproic Acid—migraine	0.00131	0.00174	CcSEcCtD
Degarelix—Pruritus—Verapamil—migraine	0.00131	0.00174	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—TAC1—migraine	0.0013	0.00564	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—NPS—migraine	0.0013	0.00564	CbGpPWpGaD
Degarelix—Back pain—Gabapentin—migraine	0.00129	0.00171	CcSEcCtD
Degarelix—Nervous system disorder—Valproic Acid—migraine	0.00129	0.00171	CcSEcCtD
Degarelix—Hypoaesthesia—Topiramate—migraine	0.00128	0.0017	CcSEcCtD
Degarelix—Muscle spasms—Gabapentin—migraine	0.00128	0.0017	CcSEcCtD
Degarelix—Vomiting—Propranolol—migraine	0.00128	0.0017	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—HTR2C—migraine	0.00127	0.00553	CbGpPWpGaD
Degarelix—Skin disorder—Valproic Acid—migraine	0.00127	0.00169	CcSEcCtD
Degarelix—Urinary tract disorder—Topiramate—migraine	0.00127	0.00169	CcSEcCtD
Degarelix—Oedema peripheral—Topiramate—migraine	0.00127	0.00168	CcSEcCtD
Degarelix—Hyperhidrosis—Valproic Acid—migraine	0.00127	0.00168	CcSEcCtD
Degarelix—Rash—Propranolol—migraine	0.00127	0.00168	CcSEcCtD
Degarelix—Dermatitis—Propranolol—migraine	0.00127	0.00168	CcSEcCtD
Degarelix—Diarrhoea—Verapamil—migraine	0.00127	0.00168	CcSEcCtD
Degarelix—Palpitations—Timolol—migraine	0.00126	0.00168	CcSEcCtD
Degarelix—Urethral disorder—Topiramate—migraine	0.00126	0.00167	CcSEcCtD
Degarelix—Vision blurred—Gabapentin—migraine	0.00126	0.00166	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—HTR2B—migraine	0.00124	0.0054	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—EDNRA—migraine	0.00124	0.00538	CbGpPWpGaD
Degarelix—Ill-defined disorder—Gabapentin—migraine	0.00124	0.00164	CcSEcCtD
Degarelix—Hypertension—Timolol—migraine	0.00124	0.00164	CcSEcCtD
Degarelix—Anaemia—Gabapentin—migraine	0.00123	0.00163	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—HTR7—migraine	0.00123	0.00534	CbGpPWpGaD
Degarelix—Hypotension—Valproic Acid—migraine	0.00123	0.00163	CcSEcCtD
Degarelix—Dizziness—Verapamil—migraine	0.00122	0.00162	CcSEcCtD
Degarelix—Arthralgia—Timolol—migraine	0.00122	0.00162	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.00121	0.0016	CcSEcCtD
Degarelix—Discomfort—Timolol—migraine	0.0012	0.0016	CcSEcCtD
Degarelix—Eye disorder—Topiramate—migraine	0.0012	0.0016	CcSEcCtD
Degarelix—Malaise—Gabapentin—migraine	0.0012	0.00159	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Valproic Acid—migraine	0.0012	0.00158	CcSEcCtD
Degarelix—Cardiac disorder—Topiramate—migraine	0.0012	0.00158	CcSEcCtD
Degarelix—Nausea—Propranolol—migraine	0.00119	0.00158	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—CALCA—migraine	0.00119	0.00518	CbGpPWpGaD
Degarelix—Dry mouth—Timolol—migraine	0.00119	0.00158	CcSEcCtD
Degarelix—Insomnia—Valproic Acid—migraine	0.00119	0.00157	CcSEcCtD
Degarelix—Palpitations—Gabapentin—migraine	0.00118	0.00156	CcSEcCtD
Degarelix—Vomiting—Verapamil—migraine	0.00118	0.00156	CcSEcCtD
Degarelix—Dyspnoea—Valproic Acid—migraine	0.00117	0.00155	CcSEcCtD
Degarelix—Angiopathy—Topiramate—migraine	0.00117	0.00155	CcSEcCtD
Degarelix—Anaphylactic shock—Timolol—migraine	0.00117	0.00155	CcSEcCtD
Degarelix—Rash—Verapamil—migraine	0.00117	0.00155	CcSEcCtD
Degarelix—Dermatitis—Verapamil—migraine	0.00117	0.00155	CcSEcCtD
Degarelix—Immune system disorder—Topiramate—migraine	0.00116	0.00154	CcSEcCtD
Degarelix—Mediastinal disorder—Topiramate—migraine	0.00116	0.00154	CcSEcCtD
Degarelix—Headache—Verapamil—migraine	0.00116	0.00154	CcSEcCtD
Degarelix—Chills—Topiramate—migraine	0.00116	0.00153	CcSEcCtD
Degarelix—Hypertension—Gabapentin—migraine	0.00115	0.00153	CcSEcCtD
Degarelix—Nervous system disorder—Timolol—migraine	0.00115	0.00152	CcSEcCtD
Degarelix—Decreased appetite—Valproic Acid—migraine	0.00114	0.00151	CcSEcCtD
Degarelix—Alopecia—Topiramate—migraine	0.00114	0.00151	CcSEcCtD
Degarelix—Arthralgia—Gabapentin—migraine	0.00113	0.0015	CcSEcCtD
Degarelix—Skin disorder—Timolol—migraine	0.00113	0.0015	CcSEcCtD
Degarelix—Gastrointestinal disorder—Valproic Acid—migraine	0.00113	0.0015	CcSEcCtD
Degarelix—Fatigue—Valproic Acid—migraine	0.00113	0.0015	CcSEcCtD
Degarelix—Hyperhidrosis—Timolol—migraine	0.00113	0.0015	CcSEcCtD
Degarelix—Mental disorder—Topiramate—migraine	0.00113	0.0015	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.00113	0.00149	CcSEcCtD
Degarelix—Constipation—Valproic Acid—migraine	0.00112	0.00149	CcSEcCtD
Degarelix—Pain—Valproic Acid—migraine	0.00112	0.00149	CcSEcCtD
Degarelix—Malnutrition—Topiramate—migraine	0.00112	0.00149	CcSEcCtD
Degarelix—Erythema—Topiramate—migraine	0.00112	0.00149	CcSEcCtD
Degarelix—Discomfort—Gabapentin—migraine	0.00112	0.00149	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—HTR7—migraine	0.00112	0.00485	CbGpPWpGaD
Degarelix—Dry mouth—Gabapentin—migraine	0.00111	0.00147	CcSEcCtD
Degarelix—Nausea—Verapamil—migraine	0.0011	0.00146	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—LRP1—migraine	0.00109	0.00475	CbGpPWpGaD
Degarelix—Hypotension—Timolol—migraine	0.00109	0.00145	CcSEcCtD
Degarelix—Anaphylactic shock—Gabapentin—migraine	0.00109	0.00144	CcSEcCtD
Degarelix—Back pain—Topiramate—migraine	0.00108	0.00144	CcSEcCtD
Degarelix—Feeling abnormal—Valproic Acid—migraine	0.00108	0.00143	CcSEcCtD
Degarelix—Muscle spasms—Topiramate—migraine	0.00108	0.00143	CcSEcCtD
Degarelix—Gastrointestinal pain—Valproic Acid—migraine	0.00107	0.00142	CcSEcCtD
Degarelix—Nervous system disorder—Gabapentin—migraine	0.00107	0.00141	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Timolol—migraine	0.00106	0.00141	CcSEcCtD
Degarelix—Vision blurred—Topiramate—migraine	0.00106	0.0014	CcSEcCtD
Degarelix—Skin disorder—Gabapentin—migraine	0.00106	0.0014	CcSEcCtD
Degarelix—Insomnia—Timolol—migraine	0.00106	0.0014	CcSEcCtD
Degarelix—Hyperhidrosis—Gabapentin—migraine	0.00105	0.00139	CcSEcCtD
Degarelix—Urticaria—Valproic Acid—migraine	0.00104	0.00138	CcSEcCtD
Degarelix—Dyspnoea—Timolol—migraine	0.00104	0.00138	CcSEcCtD
Degarelix—Ill-defined disorder—Topiramate—migraine	0.00104	0.00138	CcSEcCtD
Degarelix—Abdominal pain—Valproic Acid—migraine	0.00104	0.00137	CcSEcCtD
Degarelix—Body temperature increased—Valproic Acid—migraine	0.00104	0.00137	CcSEcCtD
Degarelix—Anaemia—Topiramate—migraine	0.00104	0.00137	CcSEcCtD
Degarelix—Hypotension—Gabapentin—migraine	0.00102	0.00135	CcSEcCtD
Degarelix—Decreased appetite—Timolol—migraine	0.00102	0.00135	CcSEcCtD
Degarelix—Malaise—Topiramate—migraine	0.00101	0.00134	CcSEcCtD
Degarelix—Gastrointestinal disorder—Timolol—migraine	0.00101	0.00134	CcSEcCtD
Degarelix—Fatigue—Timolol—migraine	0.00101	0.00133	CcSEcCtD
Degarelix—Pain—Timolol—migraine	0.000999	0.00132	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Gabapentin—migraine	0.000991	0.00131	CcSEcCtD
Degarelix—Palpitations—Topiramate—migraine	0.000991	0.00131	CcSEcCtD
Degarelix—Insomnia—Gabapentin—migraine	0.000984	0.0013	CcSEcCtD
Degarelix—Dyspnoea—Gabapentin—migraine	0.000969	0.00129	CcSEcCtD
Degarelix—Hypertension—Topiramate—migraine	0.000968	0.00128	CcSEcCtD
Degarelix—Hypersensitivity—Valproic Acid—migraine	0.000966	0.00128	CcSEcCtD
Degarelix—Feeling abnormal—Timolol—migraine	0.000962	0.00128	CcSEcCtD
Degarelix—Gastrointestinal pain—Timolol—migraine	0.000955	0.00127	CcSEcCtD
Degarelix—Arthralgia—Topiramate—migraine	0.000954	0.00127	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000948	0.00126	CcSEcCtD
Degarelix—Decreased appetite—Gabapentin—migraine	0.000945	0.00125	CcSEcCtD
Degarelix—Discomfort—Topiramate—migraine	0.000943	0.00125	CcSEcCtD
Degarelix—Asthenia—Valproic Acid—migraine	0.000941	0.00125	CcSEcCtD
Degarelix—Gastrointestinal disorder—Gabapentin—migraine	0.000939	0.00124	CcSEcCtD
Degarelix—Fatigue—Gabapentin—migraine	0.000938	0.00124	CcSEcCtD
Degarelix—Dry mouth—Topiramate—migraine	0.000933	0.00124	CcSEcCtD
Degarelix—Constipation—Gabapentin—migraine	0.00093	0.00123	CcSEcCtD
Degarelix—Pain—Gabapentin—migraine	0.00093	0.00123	CcSEcCtD
Degarelix—Pruritus—Valproic Acid—migraine	0.000928	0.00123	CcSEcCtD
Degarelix—Urticaria—Timolol—migraine	0.000928	0.00123	CcSEcCtD
Degarelix—Body temperature increased—Timolol—migraine	0.000923	0.00122	CcSEcCtD
Degarelix—Abdominal pain—Timolol—migraine	0.000923	0.00122	CcSEcCtD
Degarelix—Diarrhoea—Valproic Acid—migraine	0.000898	0.00119	CcSEcCtD
Degarelix—Nervous system disorder—Topiramate—migraine	0.000897	0.00119	CcSEcCtD
Degarelix—Feeling abnormal—Gabapentin—migraine	0.000896	0.00119	CcSEcCtD
Degarelix—Gastrointestinal pain—Gabapentin—migraine	0.000889	0.00118	CcSEcCtD
Degarelix—Skin disorder—Topiramate—migraine	0.000889	0.00118	CcSEcCtD
Degarelix—Hyperhidrosis—Topiramate—migraine	0.000884	0.00117	CcSEcCtD
Degarelix—Dizziness—Valproic Acid—migraine	0.000867	0.00115	CcSEcCtD
Degarelix—Urticaria—Gabapentin—migraine	0.000864	0.00115	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—HTR2A—migraine	0.000861	0.00374	CbGpPWpGaD
Degarelix—Hypersensitivity—Timolol—migraine	0.00086	0.00114	CcSEcCtD
Degarelix—Abdominal pain—Gabapentin—migraine	0.00086	0.00114	CcSEcCtD
Degarelix—Body temperature increased—Gabapentin—migraine	0.00086	0.00114	CcSEcCtD
Degarelix—Hypotension—Topiramate—migraine	0.000855	0.00113	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—NOTCH4—migraine	0.00084	0.00364	CbGpPWpGaD
Degarelix—Asthenia—Timolol—migraine	0.000838	0.00111	CcSEcCtD
Degarelix—Vomiting—Valproic Acid—migraine	0.000834	0.00111	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Topiramate—migraine	0.000834	0.00111	CcSEcCtD
Degarelix—Insomnia—Topiramate—migraine	0.000827	0.0011	CcSEcCtD
Degarelix—Rash—Valproic Acid—migraine	0.000827	0.0011	CcSEcCtD
Degarelix—Dermatitis—Valproic Acid—migraine	0.000826	0.0011	CcSEcCtD
Degarelix—Pruritus—Timolol—migraine	0.000826	0.0011	CcSEcCtD
Degarelix—Headache—Valproic Acid—migraine	0.000822	0.00109	CcSEcCtD
Degarelix—Dyspnoea—Topiramate—migraine	0.000816	0.00108	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—HTR1B—migraine	0.00081	0.00352	CbGpPWpGaD
Degarelix—Hypersensitivity—Gabapentin—migraine	0.000801	0.00106	CcSEcCtD
Degarelix—Diarrhoea—Timolol—migraine	0.000799	0.00106	CcSEcCtD
Degarelix—Decreased appetite—Topiramate—migraine	0.000795	0.00105	CcSEcCtD
Degarelix—Gastrointestinal disorder—Topiramate—migraine	0.00079	0.00105	CcSEcCtD
Degarelix—Fatigue—Topiramate—migraine	0.000789	0.00105	CcSEcCtD
Degarelix—Constipation—Topiramate—migraine	0.000782	0.00104	CcSEcCtD
Degarelix—Pain—Topiramate—migraine	0.000782	0.00104	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—HTR2A—migraine	0.000782	0.00339	CbGpPWpGaD
Degarelix—Asthenia—Gabapentin—migraine	0.00078	0.00103	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—HTR1A—migraine	0.00078	0.00339	CbGpPWpGaD
Degarelix—Nausea—Valproic Acid—migraine	0.000779	0.00103	CcSEcCtD
Degarelix—Dizziness—Timolol—migraine	0.000772	0.00102	CcSEcCtD
Degarelix—Pruritus—Gabapentin—migraine	0.000769	0.00102	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—PGR—migraine	0.000768	0.00333	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—NPS—migraine	0.000768	0.00333	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—TAC1—migraine	0.000768	0.00333	CbGpPWpGaD
Degarelix—Feeling abnormal—Topiramate—migraine	0.000754	0.001	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—HTR2C—migraine	0.000753	0.00327	CbGpPWpGaD
Degarelix—Gastrointestinal pain—Topiramate—migraine	0.000748	0.000992	CcSEcCtD
Degarelix—Diarrhoea—Gabapentin—migraine	0.000744	0.000986	CcSEcCtD
Degarelix—Vomiting—Timolol—migraine	0.000742	0.000984	CcSEcCtD
Degarelix—Rash—Timolol—migraine	0.000736	0.000976	CcSEcCtD
Degarelix—Dermatitis—Timolol—migraine	0.000736	0.000975	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—EDNRA—migraine	0.000733	0.00318	CbGpPWpGaD
Degarelix—Headache—Timolol—migraine	0.000732	0.00097	CcSEcCtD
Degarelix—Urticaria—Topiramate—migraine	0.000727	0.000964	CcSEcCtD
Degarelix—Body temperature increased—Topiramate—migraine	0.000723	0.000959	CcSEcCtD
Degarelix—Abdominal pain—Topiramate—migraine	0.000723	0.000959	CcSEcCtD
Degarelix—Dizziness—Gabapentin—migraine	0.000719	0.000953	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—NOTCH3—migraine	0.000714	0.0031	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CALCA—migraine	0.000705	0.00306	CbGpPWpGaD
Degarelix—Nausea—Timolol—migraine	0.000694	0.00092	CcSEcCtD
Degarelix—Vomiting—Gabapentin—migraine	0.000691	0.000917	CcSEcCtD
Degarelix—Rash—Gabapentin—migraine	0.000686	0.000909	CcSEcCtD
Degarelix—Dermatitis—Gabapentin—migraine	0.000685	0.000908	CcSEcCtD
Degarelix—Headache—Gabapentin—migraine	0.000681	0.000903	CcSEcCtD
Degarelix—Hypersensitivity—Topiramate—migraine	0.000674	0.000894	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—HTR7—migraine	0.00066	0.00286	CbGpPWpGaD
Degarelix—Asthenia—Topiramate—migraine	0.000656	0.00087	CcSEcCtD
Degarelix—Pruritus—Topiramate—migraine	0.000647	0.000858	CcSEcCtD
Degarelix—Nausea—Gabapentin—migraine	0.000646	0.000856	CcSEcCtD
Degarelix—Diarrhoea—Topiramate—migraine	0.000626	0.00083	CcSEcCtD
Degarelix—Dizziness—Topiramate—migraine	0.000605	0.000802	CcSEcCtD
Degarelix—Vomiting—Topiramate—migraine	0.000582	0.000771	CcSEcCtD
Degarelix—Rash—Topiramate—migraine	0.000577	0.000765	CcSEcCtD
Degarelix—Dermatitis—Topiramate—migraine	0.000576	0.000764	CcSEcCtD
Degarelix—Headache—Topiramate—migraine	0.000573	0.00076	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—TGFBR2—migraine	0.000568	0.00247	CbGpPWpGaD
Degarelix—Nausea—Topiramate—migraine	0.000543	0.00072	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—HTR2A—migraine	0.000462	0.00201	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—ESR1—migraine	0.00041	0.00178	CbGpPWpGaD
